Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Cichorium intybus (Esculetin).
Esculetin, a dihydroxycoumarin derivative from Cichorium intybus, exerts potent hepatoprotective and anti-inflammatory effects by modulating the Nrf2/HO-1 signaling pathway and inhibiting xanthine oxidase activity.
5281416
178.14 g/mol
1.2
6,7-dihydroxychromen-2-one
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Cichorium intybus (Esculetin) across standard consumer modalities.
The hygroscopic nature of chicory extracts requires moisture-resistant HPMC shells to prevent clumping and degradation of the phenolic compounds.
The inherent bitterness of esculetin and chicory sesquiterpene lactones necessitates high-intensity sweeteners and acidulants to mask off-notes without compromising pectin gel strength.
The low therapeutic threshold of esculetin allows for thin-film delivery, though high extract loading can compromise film flexibility and increase brittleness.
Ready to launch a product featuring Cichorium intybus (Esculetin)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Cichorium intybus (Esculetin) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Cichorium intybus (Esculetin) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation